Ortopedik Enfeksiyonlarda Moleküler Görüntülemenin Rolü

İnflamasyon, immun sistem hücrelerinin doku hasarına karşı yanıtıdır. Enfeksiyon, mikroorganizmaların varlığı ile meydana gelir. Akut ve kronik osteomiyelit, spondilodiskit ve ortopedik implant enfeksiyonları enfeksiyöz hastalıkların heterojen grubudur. Bu hastalıkların ortak yönü klinisyen, radyolog ve nükleer tıp hekimleri tarafından tanı ve tedavisinin yapılmasıdır. Enfeksiyonun erken tanısı ve lokalizasyonu, tedavinin uygun ve erken zamanda yapılabilmesi için önem taşımaktadır. Enfeksiyon sonrası dokuda oluşan patoloji radyolojik yöntemlerle gösterilmektedir. Fakat enfeksiyonun hücresel düzeyde olduğu durumlarda enfeksiyon odağının belirlenmesi açısından nükleer tıp yöntemlerinin önemi büyüktür. Galyum-67 sitrat, Teknesyum-99m (Tc-99m) nanokolloid ve Tc-99m difosfonat türevleri gibi radyofarmasötikler enfeksiyon görüntülemede sık kullanılmaktadır. Bu makalenin,ortopedik enfeksiyonların tanısında moleküler görüntüleme yöntemlerinin öneminin vurgulanmada ve klinik pratikte klinisyenlere yol gösterici olması amaçlanmıştır.

The Role of Molecular Imaging in Orthopedic Infections

Inflammation is the response of immune system cells to tissue damage. Infection is caused by the presence ofmicroorganisms. Acute and chronic osteomyelitis, spondylodiscitis and orthopedic implant infections are aheterogeneous group of infectious diseases. Clinicians, radiologists and nuclear medicine physicians diagnose andtreat them. Early diagnosis and localization of the infection is important for appropriate and early treatment.Pathological processes in tissue after infection is shown with radiological methods. However nuclear medicinemethods have great importance for the determination of the infection focus at the cellular level.Radiopharmaceuticals such as Gallium-67 citrate, Technetium-99m (Tc-99m) nanocolloid and Tc-99mdiphosphonate derivatives are commonly used for infection imaging. This article aims to underline importance ofmolecular imaging methods for diagnosis of orthopedics infections and guidance for clinicians in clinical practice.

___

  • 1. Ziessman H, O'Malley J, Thrall J. Nuclear Medicine: The Reguisities. 4th ed. Philadelphia, Elseiver. 2014.
  • 2. Alazraki NP. Diagnosing prosthetic joint infection. J Nucl Med. 1990;31:1955-7.
  • 3. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3-15.
  • 4. Elgazzar AH. The pathophysiologic basic of nuclear medicine. 2nd. ed. New York, Springer, 2006.
  • 5. Cook GJR, Maisey MN, Britton KE, Chengazi V. Clinical Nuclear Medicine. 4th ed. London, 2006.
  • 6. Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med. 2009;39:11-26.
  • 7. Sharp PF, Gemmell HG, Murray AD. Practical Nuclear Medicine.3rd ed. London, Springer. 2005.
  • 8. De Winter F, Gemmel F, Van Laere K, De Winter O, Poffijn B, Dierckx RA et al. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging. 2004;31:233-9.
  • 9. Palestro CJ. Radionuclide imaging of osteomyelitis. Semin Nucl. Med. 2015;45:32-46.
  • 10. Wukich DK, Abreu SH, Callaghan JJ, Van Nostrand D, Savory CG, Eggli DF et al. Diagnosis of infection by preoperative scintigraphy with indium-labeled white blood cells. J Bone Joint Surg Am. 1987;69:1353-60.
  • 11. Palestro CJ, Love C, Tronco GG, Tomas MB, Rini JN. Combined labeled leukocyte and technetium99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics. 2006;26:859-70.
  • 12. Palestro CJ. Nuclear medicine, the painful prosthetic joint, and orthopedic infection. J Nucl Med. 2003;44:927-9.
  • 13. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants, J Nucl Med. 2001;42:44-48.
  • 14. Reinartz P, Mumme T, Hermanns B, Cremerius U, Wirtz DC, Schaefer WM et al. Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg Br. 2005;87:465-70.
  • 15. Volpe L, Indellı PF, Latella L, Poli P, Yakupoglu J, Marcucci M. Periprosthetic joint infections: a clinical practice algorithm. Joints. 2015;2:169-74.
  • 16. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66-78.
  • 17. Merkel KD, Brown ML, Fitzgerald RH Jr. Sequential technetium-99m HMDP-gallium-67 citrate imaging for the evaluation of infection in the painful prosthesis. J Nucl Med. 1986;27:1413-7.
  • 18. Kraemer WJ, Saplys R, Waddell JP, Morton J. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J Arthroplasty. 1993;8:611-6.
  • 19. Lieberman JR, Huo MH, Schneider R, Salvati EA, Rodi S. Evaluation of painful hip arthroplasties. Are technetium bone scans necessary? J Bone Joint Surg Br. 1993;75:475-8.
  • 20. Rushton N, Coakley AJ, Tudor J, Wraight EP. The value of technetium and gallium scanning in assessing pain after total hip replacement. J Bone Joint Surg Br. 1982;64:313-8.
  • 21. Palestro CJ. Nuclear medicine and the failed joint replacement: Past, present, and future. World J Radiol. 2014;28;6:446-58.
  • 22. Love C, Marwin SE, Tomas MB, Krauss ES, Tronco GG, Bhargava KK et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99Tc-sulfur colloid marrow imaging. J Nucl Med. 2004;45:1864-71.
  • 23. Johnson JA, Christie MJ, Sandler MP, Parks PF Jr, Homra L, Kaye JJ. Detection of occult infection following total joint artroplasty using sequential technetium-99m HDP bone scintigraphy and indium-111 WBC imaging. J Nucl Med. 1998;29:1347-53.
  • 24. Pelosi E, Baiocco C, Pennone M, Migliaretti G, Varetto T, Maiello A et al. 99mTc-HMPAO-leukocyte scintigraphy in patients with symptomatic total hip or knee arthroplasty: improved diagnostic accuracy by means of semiquantitative evaluation. J Nucl Med. 2004;45:438-44.
  • 25. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics. 2001;21:1229-38.
  • 26. Rosenthall L, Lepanto L, Raymond F. Radiophosphate uptake in asymptomatic knee artroplasty. J Nucl Med. 1987;28:1546- 9.
  • 27. Yue B, Tang T. The use of nuclear imaging for the diagnosis of periprosthetic infection after knee and hip arthroplasties. Nucl Med Commun. 2015;36:305-11.
  • 28. Pring DJ, Henderson RG, Keshavarzian A, Rivett AG, Krausz T, Coombs RR et al. Indium-granulocyte scanning in the painful prosthetic joint, AJR Am J Roentgenol. 1986;147:167-72.
  • 29. Palestro CJ, Love C. Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties. Semin Nucl Med. 2017;47:630-8.
  • 30. Palestro CJ, Kim CK, Swyer AJ, Capozzi JD, Solomon RW, Goldsmith SJ. Total-hip arthroplasty: periprosthetic indium111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J Nucl Med. 1990;31:1950-5.
  • 31. De Winter F, Van de Wiele C, Dumont F, Van Durme J, Solanki K, Britton K et al. Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection. Eur J Nucl Med. 2001;28:570-4.